Quarterly Report Vigmed Holding AB, January 1 – March 31, 2014

Report this content

During the first quarter of 2014, focus has been optimization of the assembly lines for the product range CLiP®Ven Ported. Production of Vigmed CLiP®Ven IV catheters at HMD's new factory in India has now started, and build-up of adequate stock levels for launch is in progress.

Formal distribution partnerships for Scandinavia (Sweden, Denmark and Norway), Greece and Piemonte / Valle d’Aosta in Italy have been established in the first quarter.

The Board of Vigmed Holding AB

For further information contact:

Chairman of the board, Lennart Holm 46 70-630 8562 or CEO, Finn Ketler 46 42 600 5311

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 15 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor

Tags: